Standout Papers

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and at... 2023 2026 2024111
  1. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis (2023)
    Gerd R Burmester, Stanley Cohen et al. RMD Open

Immediate Impact

61 standout
Sub-graph 1 of 23

Citing Papers

Advances in conducting nanocomposite hydrogels for wearable biomonitoring
2025 Standout
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
2 intermediate papers

Works of Hannah Palac being referenced

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis
2023 Standout
The relationship between sweat chloride levels and mortality in cystic fibrosis varies by individual genotype
2017

Author Peers

Author Last Decade Papers Cites
Hannah Palac 119 123 123 266 146 48 1000
Emelie Heintz 115 79 158 193 194 42 1.1k
David White 31 98 77 97 210 52 873
Enrico De Nigris 380 69 164 132 79 39 1.1k
John L. Bell 288 97 322 100 63 68 1.4k
Denis J. Lynch 95 261 113 84 312 46 1.3k
Kwonho Jeong 82 251 174 73 244 48 1.3k
Emma Everson-Hock 30 253 80 233 329 46 1.4k
AnnMarie Groarke 120 80 33 130 181 40 926
Concepción Fernández 222 106 51 82 120 54 956
Kathryn L. Anderson 96 123 72 50 328 31 1.3k

All Works

Loading papers...

Rankless by CCL
2026